PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.78%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-5.59%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-26.75%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-24.32%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-22.82%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-22.81%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-22.81%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.00%
Share reduction while 3391.T is at 0.07%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
152.83%
10Y revenue/share CAGR 1.25-1.5x 3391.T's 138.52%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
51.72%
5Y revenue/share CAGR above 1.5x 3391.T's 25.90%. David Dodd would look for consistent product or market expansions fueling outperformance.
34.22%
3Y revenue/share CAGR above 1.5x 3391.T's 15.69%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
137.62%
Positive 10Y CAGR while 3391.T is negative. John Neff might see a substantial advantage in bottom-line trajectory.
68.73%
Positive 5Y CAGR while 3391.T is negative. John Neff might view this as a strong mid-term relative advantage.
25.56%
Positive short-term CAGR while 3391.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
310.55%
10Y equity/share CAGR above 1.5x 3391.T's 128.10%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
81.59%
5Y equity/share CAGR above 1.5x 3391.T's 25.43%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
35.06%
3Y equity/share CAGR above 1.5x 3391.T's 6.75%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
136.36%
Below 50% of 3391.T's 339.72%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
160.00%
5Y dividend/share CAGR 1.25-1.5x 3391.T's 109.46%. Bruce Berkowitz verifies that high dividend hikes remain sustainable, not a sign of over-distribution.
62.50%
3Y dividend/share CAGR at 50-75% of 3391.T's 85.63%. Martin Whitman might see a weaker short-term approach to distributing cash.
3.80%
Our AR growth while 3391.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
8.07%
Inventory growth well above 3391.T's 3.23%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.32%
Positive asset growth while 3391.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
2.65%
Positive BV/share change while 3391.T is negative. John Neff sees a clear edge over a competitor losing equity.
-4.27%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-0.81%
We cut SG&A while 3391.T invests at 2.21%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.